• Rosiglitazone: A PPARG Variant Rescue Framework

  2026-08-14

  Rosiglitazone, also known as Brl-49653, offers a powerful way to study how pathogenic PPARG variants alter adipocyte biology. This article presents a genotype-aware assay framework that connects receptor activity, protein stability, mitochondrial function, and insulin sensitivity modulation.

• Chloroquine: A Pharmacogenomic Research Framework

  2026-08-13

  Chloroquine research is moving beyond single-pathway explanations. This guide connects lysosomal biology, assay design, and CYP pharmacogenomics to improve interpretation across malaria, autoimmune, antiviral, and cancer models.

• Patient-Derived 3D Spheroids in Prostate Cancer

  2026-08-13

  Linxweiler and colleagues developed viable three-dimensional spheroid cultures from radical prostatectomy specimens, creating a patient-derived model for organ-confined prostate cancer. The cultures retained key epithelial and androgen receptor markers, could be cryopreserved, and showed differential responses to androgen receptor antagonists, docetaxel, and abiraterone.

• Z-WEHD-FMK: A Practical Guide to Pyroptosis

  2026-08-12

  Explore how Z-WEHD-FMK can clarify inflammatory caspase activity, pyroptosis, and pathogen-driven Golgi remodeling. This guide connects inhibitor selection with mechanistic assay design using recent HOXC8–caspase-1 findings.

• Clasto-Lactacystin β-lactone in Cell Assays

  2026-08-12

  This scenario-based guide explains how Clasto-Lactacystin β-lactone, SKU A2578, can strengthen cell viability, proliferation, cytotoxicity, and proteasome inhibition assays. It covers mechanism, solvent controls, optimization, interpretation, and practical criteria for selecting a reliable research-grade reagent.

• FAISL, Calpain 2, and FAK in TNBC

  2026-08-11

  This Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing calpain 2-mediated proteolysis. The work connects RNA–protein interaction, focal adhesion biology, and TNBC metastasis, while demonstrating that FAISL-targeting nanoparticles can suppress tumor growth and dissemination in mouse models.

• Puromycin Aminonucleoside in Podocyte Models

  2026-08-10

  Puromycin aminonucleoside is a versatile nephrotoxic probe for connecting podocyte morphology, proteinuria, and glomerular pathology. This guide adds a phenotype-to-proteome framework, showing how DrPISA-inspired fraction-aware analysis could improve mechanistic decisions while preserving clear experimental boundaries.

• Intravesical p21 mRNA–LNP Therapy for Bladder Cancer

  2026-08-09

  The 2026 FASEB Journal study developed lipid nanoparticles carrying chemically modified p21 mRNA for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, restrained cell-cycle progression, and suppressed orthotopic tumor growth while limiting systemic exposure, providing a preclinical framework for tumor-suppressor replacement therapy.

• Acridine Orange hydrochloride: Practical Staining Guide

  2026-08-08

  Acridine Orange hydrochloride provides differential green and red fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric assays. This guide explains preparation, controls, acquisition, and troubleshooting while defining why the dye should not be treated as an absolute DNA/RNA identifier or stored as a long-term solution.

• Cannabidiol, CB1 Signaling, and Orofacial Pain

  2026-08-07

  This 2026 study shows that cannabidiol (CBD) reduces inflammatory pain while also improving pain-associated anxiety, depressive-like behavior, and cognitive deficits in mice. Its central innovation is the separation of peripheral CB2-linked anti-inflammatory effects from central CB1- and serotonin-related modulation of pain affect and cognition.

• Synergistic Meiotic Induction in Mouse SSCs by RA and Nutrie

  2026-08-07

  This study establishes a robust in vitro protocol enabling meiotic initiation in long-term cultured mouse spermatogonial stem cells (SSCs) through the combined application of retinoic acid and nutrient restriction. The findings provide a mechanistic advance for germ cell biology, significantly enhancing the utility of SSC cultures for reproductive and regenerative research.

• GSK-923295: Advancing Centromere Biology in Cancer Research

  2026-08-06

  Explore how GSK-923295, a potent CENP-E inhibitor from APExBIO, is transforming translational cancer research by enabling targeted disruption of mitotic fidelity. This article bridges recent mechanistic insights on centromere integrity, especially the role of CTCF, with strategic guidance for assay design and therapeutic exploration. Integrating evidence from recent studies, we highlight best practices, competitive context, and visionary directions for leveraging GSK-923295 in next-generation cancer research.

• Etoposide (VP-16) SKU A1971: Reliable Solutions for DNA Dama

  2026-08-06

  This authoritative guide presents scenario-driven, evidence-based insights for optimizing DNA damage and apoptosis assays using Etoposide (VP-16), SKU A1971. Drawing on quantitative data and real laboratory challenges, it demonstrates how APExBIO's Etoposide supports reproducible research in cancer biology and drug development.

• JSH-23: Precision NF-κB Inhibition for Inflammation Research

  2026-08-05

  JSH-23 stands out as a selective NF-κB inhibitor, enabling reproducible dissection of inflammatory signaling and pro-inflammatory cytokine regulation in both cell-based and animal models. Its distinctive mechanism and validated workflow optimizations make it indispensable for translational inflammation research and troubleshooting complex experimental designs.

• Chlorin e6 Photosensitizer: Applied Protocols & PDT Innovati

  2026-08-05

  Chlorin e6 (Ce6) empowers advanced photodynamic therapy workflows, offering potent ROS-driven cytotoxicity for both anticancer and antibacterial research. This article bridges cutting-edge material integration with protocol optimization and troubleshooting, translating recent breakthroughs into actionable steps for experimental success.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page